FIELD: medicine; pharmacology.
SUBSTANCE: invention relates to the use of an inverse H3R agonist for treating sleep disorder during shift work. In particular, use of 1-(1-methyl-6-oxo-1,6-dihydropyridazin-3-yl)piperidin-4-yl-4-cyclobutylpiperazine-1-carboxylate or a pharmaceutically acceptable salt thereof for the treatment of excessive sleepiness during shift work is described.
EFFECT: providing effective use of therapeutic agents for treating sleep disorders during shift work.
11 cl, 2 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS FOR TREATMENT OF DISORDERS OF CIRCADIAN SLEEP RHYTHM | 2017 |
|
RU2763493C2 |
| APPLICATION OF FLECAINIDE AS ANTICONNEXIN AGENT AND METHOD OF POTENTIATION OF EFFECTS OF PSYCHOTROPIC MEDICINES | 2014 |
|
RU2661026C2 |
| METHOD OF TREATING EXCESSIVE DAYTIME SLEEPINESS (VERSIONS) | 2006 |
|
RU2417077C2 |
| NEW COMBINATIONS OF H3 RECEPTOR ANTAGONISTS AND NOREPINEPHRINE REUPTAKE INHIBITORS AND THEIR THERAPEUTIC USE | 2019 |
|
RU2809163C2 |
| METHOD OF TREATING FIBROMYALGIA SYNDROME | 2010 |
|
RU2557533C2 |
| TREATMENT OF CIRCADIAN RHYTHM DISORDERS | 2013 |
|
RU2748386C2 |
| USING MIRTAZAPINE FOR TREATMENT OF SLEEP DISORDER | 2001 |
|
RU2270680C2 |
| COMPOUNDS USED FOR SLEEP/WAKEFULNESS CYCLE NORMALISATION | 2003 |
|
RU2366428C2 |
| MELATONIN AGONIST THERAPY | 2007 |
|
RU2488392C2 |
| METHODS FOR TREATING AND PREVENTING FATIGUE | 2010 |
|
RU2567801C2 |
